47.73.Z - Dispensing chemist in specialised stores
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
47.29.Z - Other retail sale of food in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Total operating revenue | 2 | 0,7 | 0,5 | -34 |
Net sales | 263,5 | |||
Liabilities and provisions | 0,4 | 0,5 | 3,5 | 542 |
Equity | 0,1 | 0,1 | -0,1 | -296,8 |
Total assets | 0,5 | 0,6 | 3,3 | 440,5 |
Depreciation | 29,9 | |||
Cash and cash equivalents | -82,7 | |||
Gross profit / loss | -0,2 | -0 | -0,2 | -398,4 |
EBITDA | 174,5 | |||
Operating profit (EBIT) | 126,6 | |||
Net profit / loss | -0,2 | -0 | -0,2 | -398,4 |
Current assets | 0,4 | 0,4 | 3,1 | 638,7 |
% | % | % | p.p. | |
Return on equity (ROE) | -132,9 | -59,6 | 73,3 | |
Return on sales (ROS) | -8 | -6,1 | -46,1 | -40 |
Equity ratio | 22,6 | 12,1 | -4,4 | -16,5 |
EBITDA margin | 7,3 | |||
Gross profit margin | -8 | -6,1 | -46,1 | -40 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | -85 | |||
Current ratio | 0 | |||
Net debt to EBITDA | 1,7 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.